VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
about
Replicon RNA Viral Vectors as VaccinesPseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.Viral and Synthetic RNA Vector Technologies and Applications.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
P2860
Q28076639-0E077CE7-EFAF-45A3-AD0E-3E126C0EA3AFQ34719449-C6767CCC-8E36-449B-9346-635BA6664903Q36736786-6161F2A2-7AA8-4040-9FFD-08358BAE2F0CQ37292354-C4E4FAF5-3622-43F9-9D02-E7C9E94FA4C2Q37417618-9633235D-7798-40E5-AC5F-9460ABAB7415Q38885624-DA489AA0-D698-46D4-A73B-481BFA8E58B7Q40052567-C26B1EC6-B871-46E4-B7EC-5353443AD9E4Q52677347-4D659C86-01FC-4D1B-8E73-2893A57718A3Q54378300-92641DD3-63CC-4744-BAD2-72E6BB6620C3Q55652233-A030FC8E-DC21-4935-800B-3A0FF8D4D59C
P2860
VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@en
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@nl
type
label
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@en
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@nl
prefLabel
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@en
VSV-GP: a potent viral vaccine ...... se upon repeated applications.
@nl
P2093
P2860
P50
P356
P1433
P1476
VSV-GP: a potent viral vaccine ...... nse upon repeated applications
@en
P2093
Alexander Muik
Dorothee von Laer
Florian Kreppel
Lisa Egerer
Reinhard Tober
Sandra Behmüller
Ute Greczmiel
P2860
P304
P356
10.1128/JVI.03276-13
P407
P577
2014-02-19T00:00:00Z